For the first time ever, researchers are administering LSD to patients in a Phase 3 clinical trial. The new study focuses on whether the psychedelic can be used to effectively treat generalized ...
Boyd Watterson Asset Management is pleased to announce the appointment of Don Haisch as its new Global Chief Financial Officer (CFO), marking a pivota ...
Dairy Foods names New York City-based Chobani LLC as its 2024 Processor of the Year, honoring the company’s impressive humanitarian efforts, its entrance into new dairy and non-dairy markets, and its ...
FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of David DeLucia to Chief Financial Officer (CFO), effective December 16, 2024. The company ...